Postes actifs de Yves Dudal
Sociétés | Poste | Début | Fin |
---|---|---|---|
Envolure SAS
Envolure SAS Medical SpecialtiesHealth Technology Envolure SAS designs, develops and commercializes laboratory kits. It offers its products for the diagnostics and treatment of waste water. Its products are sold and marketed under the brand names of enverdi, envital, envifa, enprint and enalyse. The company was founded by Nathalie Pautremat and Yves Dudal on February 26, 2010 and is headquartered in Montpellier, France. | Président | 06/03/2010 | - |
Fondateur | 28/01/2010 | - | |
INOFEA AG
INOFEA AG Packaged SoftwareTechnology Services INOFEA AG is a Swiss biotech company founded in 2014 that works closely with its clients to provide them with a complex line of services that sustain their processes and products. The company is based in Muttenz, Switzerland. The company has developed a patented platform technology called enzzen® that empowers enzymes to fit industrial applications. Enzymes are protein molecules that carry a vital energy factor needed for every chemical reaction and reactions that occur in any living organism. INOFEA has successfully demonstrated the added-value of their technology for enzyme-mediated bioconjugation or post-translational modifications of antibodies or other large molecules. Anne Timm has been the CEO of the company since 2018. | Directeur/Membre du Conseil | - | - |
Perseo pharma AG
Perseo pharma AG BiotechnologyHealth Technology Perseo pharma AG is a Swiss preclinical stage biopharmaceutical company that focuses on discovering and developing enzyme therapeutics for the treatment of digestive diseases. The company is based in Muttenz, Switzerland. The company has entered into a strategic research and development collaboration with Nestlé Health Science to develop novel therapies for digestive diseases. Perseo pharma's innovative technology is based on therapeutic enzymes that are protected in a nano shield with muco-adhesive coating. The company is a spin-off from the University of Applied Sciences (FHNW), School of Life Sciences in Switzerland, and was founded by Prof. Dr. Patrick Shahgaldian. Yves Dudal has been the CEO of the company since 2019. | Directeur/Membre du Conseil | 13/05/2019 | - |
Directeur Général | 13/05/2019 | - |
Historique de carrière de Yves Dudal
Statistiques
Internationale
Suisse | 3 |
France | 2 |
Opérationnelle
Director/Board Member | 2 |
Chairman | 1 |
Founder | 1 |
Sectorielle
Health Technology | 3 |
Technology Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 3 |
---|---|
Envolure SAS
Envolure SAS Medical SpecialtiesHealth Technology Envolure SAS designs, develops and commercializes laboratory kits. It offers its products for the diagnostics and treatment of waste water. Its products are sold and marketed under the brand names of enverdi, envital, envifa, enprint and enalyse. The company was founded by Nathalie Pautremat and Yves Dudal on February 26, 2010 and is headquartered in Montpellier, France. | Health Technology |
INOFEA AG
INOFEA AG Packaged SoftwareTechnology Services INOFEA AG is a Swiss biotech company founded in 2014 that works closely with its clients to provide them with a complex line of services that sustain their processes and products. The company is based in Muttenz, Switzerland. The company has developed a patented platform technology called enzzen® that empowers enzymes to fit industrial applications. Enzymes are protein molecules that carry a vital energy factor needed for every chemical reaction and reactions that occur in any living organism. INOFEA has successfully demonstrated the added-value of their technology for enzyme-mediated bioconjugation or post-translational modifications of antibodies or other large molecules. Anne Timm has been the CEO of the company since 2018. | Technology Services |
Perseo pharma AG
Perseo pharma AG BiotechnologyHealth Technology Perseo pharma AG is a Swiss preclinical stage biopharmaceutical company that focuses on discovering and developing enzyme therapeutics for the treatment of digestive diseases. The company is based in Muttenz, Switzerland. The company has entered into a strategic research and development collaboration with Nestlé Health Science to develop novel therapies for digestive diseases. Perseo pharma's innovative technology is based on therapeutic enzymes that are protected in a nano shield with muco-adhesive coating. The company is a spin-off from the University of Applied Sciences (FHNW), School of Life Sciences in Switzerland, and was founded by Prof. Dr. Patrick Shahgaldian. Yves Dudal has been the CEO of the company since 2019. | Health Technology |
- Bourse
- Insiders
- Yves Dudal
- Expérience